# US 8,785,389 B2 · Polymeric collagen biomaterials > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 8,785,389 B2 - Document ID: US8785389B2 - Status: Granted - Kind: B2 - Application number: 13/384,390 - Filed: 2010-07-16 - Published: 2012-05-31 - Granted: 2014-07-22 - Earliest claimed: 2009-07-16 - Assignees: UCL Business PLC - Applicants: Robert Brown; Burcak Alp; Hector Hadjipanayi - Inventors: Robert Brown; Burcak Alp; Hector Hadjipanayi - Web page: https://patentgrep.com/patent/US8785389B2 ## CPC - A61L 27/24: Collagen - A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment} - A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)} - A61P 17/00: Drugs for dermatological disorders - A61L 2430/40: Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking - A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K) - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract This invention relates to the production of biomaterials from polymeric collagen (PC) and its seeding with cells and other components of biomaterials. Polymeric collagen is isolated from tissue, suspended in an acidic solution, and then neutralized at low temperature. The neutralized suspension is then seeded with biomaterial components, such as cells, and the polymeric collagen aggregated to form a biomaterial comprising the biomaterial components. Polymeric collagen biomaterials produced as described herein may therefore be useful in a range of tissue engineering applications. ## Claims ### Claim 1 A method of producing a polymeric collagen biomaterial Comprising: (i) depleting calcium from a sample of collagen tissue, optionally a sample of tendon or ligament from a bird or a mammal, (ii) dispersing the calcium depleted tissue sample in an acidic solution to produce a tissue suspension, (iii) neutralising the tissue suspension and aggregating the polymeric collagen therein, (iv) removing aggregated polymeric collagen from the neutralised tissue suspension, (v) dispersing the aggregated polymeric collagen in an acidic solution to produce a polymeric collagen suspension, (vi) neutralising the polymeric collagen suspension and aggregating the polymeric collagen therein, (vii) removing aggregated polymeric collagen from the neutralised suspension, (viii) performing one or more repetitions of steps (v) to (vii), (ix) dispersing the aggregated polymeric collagen in an acidic solution to produce a purified polymeric collagen suspension, (x) neutralising the purified polymeric collagen suspension at 0 to IO° C. without aggregation of the polymeric collagen therein, (xi) incorporating one or more biomaterial components into the neutralised suspension, and; (xii) aggregating the polymeric collagen in the suspension resulted from the step (xi) to form said polymeric collagen biomaterial. ### Claim 2 (depends on 1) The method according to claim 1 wherein the polymeric collagen is aggregated by agitation of the suspension in one or both of steps (iii) and (vi). ### Claim 3 (depends on 1) The method according to claim 1 wherein the collagen tissue sample is a powder, wherein the powder is prepared by a process comprising (i) fragmenting native collagen tissue wherein said fragmenting results in tissue fragments, (ii) freezing the tissue fragments and (iii) pulverising the frozen tissue fragments. ### Claim 4 (depends on 1) The method according to claim 1 wherein calcium is depleted from the collagen tissue sample in step (i) by suspending the sample in 4% (w/v) EDTA at pH 7 to 8 for 24 hours or more at low temperature; or wherein the calcium depleted tissue sample resulted from step (ii) is dispersed in the acidic solution ) at low temperature, optionally 0.2M acetic acid at 0 to 10° C., to produce the tissue suspension; or, wherein the tissue suspension in step (iii) is neutralised at low temperature. ### Claim 5 (depends on 1) The method according to claim 1 wherein steps v) and vi) are performed at low temperature. ### Claim 6 (depends on 1) The method according to claim 1 wherein steps (v) to (vii) are repeated up to 6 times. ### Claim 7 (depends on 1) The method according to claim 1 wherein the purified polymeric collagen suspension is neutralised without substantial agitation in step (x) to prevent aggregation of the polymeric collagen. ### Claim 8 (depends on 1) The method according to claim 1 wherein the biomaterial components comprise one or more of viable mammalian cells, solid elements and therapeutic agents. ### Claim 9 (depends on 1) The method according to claim 1 wherein the polymeric collagen is aggregated after incorporation of the biomaterial components by incubating at 0 to 10° C., or 0 to 5° C. without stirring or agitation. ### Claim 10 (depends on 1) The method according to claim 1 wherein, after incorporation of the biomaterial components, shear stress is applied to the polymeric collagen comprising collagen fibers during aggregation in step (xii) to align said collagen fibrils. ### Claim 11 (depends on 1) The method according to claim 1 wherein the biomaterial is molded, shaped, embossed and/or subjected to plastic compaction. ### Claim 12 (depends on 1) A polymeric collagen biomaterial obtained by the method according to claim 1. ### Claim 13 (depends on 12) A tissue equivalent implant comprising a biomaterial according to claim 12.